VolitionRx Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
VolitionRx Limited income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue1.230.780.310.090.010.020.00
Cost of Revenue0.000.000.000.000.000.000.00
Gross Profit1.230.780.310.090.010.020.00
Operating Expenses
Research & Development14.4119.5515.3313.0214.5310.3610.91
Selling, General & Administrative13.6417.2116.4015.406.735.706.95
Operating Expenses28.2636.7630.8628.4221.2616.0617.90
Operating Income-27.02-35.99-30.55-28.33-21.25-16.04-17.90
Other Income/Expense
Interest Income0.010.090.130.000.050.000.00
Interest Expense0.34-0.220.17-0.16-0.130.000.11
Other Income/Expense-0.230.22-1.231.520.64-0.350.00
Income
Income Before Tax-27.26-35.68-30.60-26.99-20.40-15.71-18.01
Income Tax Expense0.000.000.000.000.000.000.00
Net Income-26.97-35.32-30.27-26.81-20.35-15.71-18.01
Net Income - Continuous Operations-26.97-35.68-30.60-26.990.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-25.58-34.04-29.24-27.39-20.53-14.90-17.26
EBIT-27.02-35.46-30.43-28.33-21.25-15.58-17.90
Depreciation & Amortization1.341.150.350.950.720.000.04
Earnings Per Share
Basic EPS---1.00-1.00---1.00
Diluted EPS---1.00-1.00---1.00
Basic Shares Outstanding86.5371.2355.3552.6645.2839.1831.39
Diluted Shares Outstanding86.5371.2355.3552.6645.2839.1831.39